Cargando…

PLK1, A Potential Target for Cancer Therapy

Polo-like kinase 1 (PLK1) plays an important role in the initiation, maintenance, and completion of mitosis. Dysfunction of PLK1 may promote cancerous transformation and drive its progression. PLK1 overexpression has been found in a variety of human cancers and was associated with poor prognoses in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Zhixian, Sun, Qingrong, Wang, Xiaosheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Neoplasia Press 2016
Materias:	Review article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5124362/ https://www.ncbi.nlm.nih.gov/pubmed/27888710 http://dx.doi.org/10.1016/j.tranon.2016.10.003

Ejemplares similares

Exploration of the Combination of PLK1 Inhibition with Immunotherapy in Cancer Treatment
por: Li, Mengyuan, et al.
Publicado: (2018)

PLK-1 Targeted Inhibitors and Their Potential against Tumorigenesis
por: Kumar, Shiv, et al.
Publicado: (2015)

PLK1 inhibition-based combination therapies for cancer management
por: Su, Shengqin, et al.
Publicado: (2021)

Role of Polo-like Kinases Plk1 and Plk4 in the Initiation of Centriole Duplication—Impact on Cancer
por: Hoffmann, Ingrid
Publicado: (2022)

Co‐Targeting Plk1 and DNMT3a in Advanced Prostate Cancer
por: Zhang, Zhuangzhuang, et al.
Publicado: (2021)

Co‐Targeting Plk1 and DNMT3a in Advanced Prostate Cancer
por: Zhang, Zhuangzhuang, et al.
Publicado: (2022)

Molecular dynamics of PLK1 during mitosis
por: Schmucker, Stephane, et al.
Publicado: (2014)

Multiple Roles of PLK1 in Mitosis and Meiosis
por: Kalous, Jaroslav, et al.
Publicado: (2023)

TP53 mutations, expression and interaction networks in human cancers
por: Wang, Xiaosheng, et al.
Publicado: (2016)

The expression and clinical significance of PLK1/p-PLK1 protein in NK/T cell Lymphoma
por: Zhang, Zhiqi, et al.
Publicado: (2023)

PLK1 as one novel target for the poor prognosis of bladder cancer: An observational study
por: Liu, Bin, et al.
Publicado: (2022)

Molecular Targeting of the Oncoprotein PLK1 in Pediatric Acute Myeloid Leukemia: RO3280, a Novel PLK1 Inhibitor, Induces Apoptosis in Leukemia Cells
por: Wang, Na-Na, et al.
Publicado: (2015)

The Cancer Omics Atlas: an integrative resource for cancer omics annotations
por: Sun, Qingrong, et al.
Publicado: (2018)

Correction to: The Cancer Omics Atlas: an integrative resource for cancer omics annotations
por: Sun, Qingrong, et al.
Publicado: (2018)

BORA-dependent PLK1 regulation: A new weapon for cancer therapy?
por: Cirillo, Luca, et al.
Publicado: (2016)

PLK1 Is a Potential Prognostic Factor Associated with the Tumor Microenvironment in Lung Adenocarcinoma
por: Wang, Lina, et al.
Publicado: (2022)

Transcriptional landscape of human cancers
por: Li, Mengyuan, et al.
Publicado: (2017)

Polo-like kinase 1 (Plk1): an Unexpected Player in DNA Replication
por: Song, Bing, et al.
Publicado: (2012)

Integrated bioinformatics analysis reveals CDK1 and PLK1 as potential therapeutic targets of lung adenocarcinoma
por: Li, Shuzhen, et al.
Publicado: (2021)

PLK1 targets CtIP to promote microhomology-mediated end joining
por: Wang, Hailong, et al.
Publicado: (2018)

Therapeutic Targeting PLK1 by ON-01910.Na Is Effective in Local Treatment of Retinoblastoma
por: Ma, Huan, et al.
Publicado: (2021)

PLK1 has tumor-suppressive potential in APC-truncated colon cancer cells
por: Raab, Monika, et al.
Publicado: (2018)

Tumor Suppressor PLK2 May Serve as a Biomarker in Triple-Negative Breast Cancer for Improved Response to PLK1 Therapeutics
por: Gao, Yang, et al.
Publicado: (2021)

Bioinformatics Analysis Highlight Differentially Expressed CCNB1 and PLK1 Genes as Potential Anti-Breast Cancer Drug Targets and Prognostic Markers
por: Fang, Leiming, et al.
Publicado: (2022)

Toxicity modelling of Plk1-targeted therapies in genetically engineered mice and cultured primary mammalian cells
por: Raab, Monika, et al.
Publicado: (2011)

A Novel Allosteric Inhibitor Targets PLK1 in Triple Negative Breast Cancer Cells
por: Patel, Jankiben R., et al.
Publicado: (2022)

Regulatory functional territory of PLK-1 and their substrates beyond mitosis
por: Kumar, Shiv, et al.
Publicado: (2017)

The expression of PLK-1 in cervical carcinoma: a possible target for enhancing chemosensitivity
por: Zhang, Yuan, et al.
Publicado: (2009)

Synergistic effects of FGFR1 and PLK1 inhibitors target a metabolic liability in KRAS‐mutant cancer
por: Yang, Zhang, et al.
Publicado: (2021)

Identification of PLK1 as a New Therapeutic Target in Mucinous Ovarian Carcinoma
por: Affatato, Roberta, et al.
Publicado: (2020)

Plk4/SAK/ZYG-1 in the regulation of centriole duplication
por: Pearson, Chad G, et al.
Publicado: (2010)

A narrative review of multiple mechanisms of progranulin in cancer: a potential target for anti-cancer therapy
por: Zhou, Chenhui, et al.
Publicado: (2021)

Development of a nanoparticle-based immunotherapy targeting PD-L1 and PLK1 for lung cancer treatment
por: Reda, Moataz, et al.
Publicado: (2022)

Self-regulated mechanism of Plk1 localization to kinetochores: lessons from the Plk1-PBIP1 interaction
por: Lee, Kyung S, et al.
Publicado: (2008)

Differential Dependency of Human Pancreatic Cancer Cells on Targeting PTEN via PLK 1 Expression
por: Lee, Jungwhoi, et al.
Publicado: (2020)

Polo-Like Kinase 4’s Critical Role in Cancer Development and Strategies for Plk4-Targeted Therapy
por: Zhang, Xiaoyang, et al.
Publicado: (2021)

Computational Design of Targeted Inhibitors of Polo-Like Kinase 1 (Plk1)
por: Jani, Krupa S., et al.
Publicado: (2012)

PLK1 targets NOTCH1 during DNA damage and mitotic progression
por: De Blasio, Carlo, et al.
Publicado: (2019)

Polo-like kinases as potential targets and PLK2 as a novel biomarker for the prognosis of human glioblastoma
por: Ding, Yiming, et al.
Publicado: (2022)

Plk1 in Asthma: Ready for Primetime?
por: Tam, John Kit Chung, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_17vvj1h0l24f9pt1405gsiet2k